Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Contents
Current Drug Targets, Volume 16 - Number 4
Editorial
CYLD-Mediated Signaling and Diseases
, 16(4): 284 - 294Bryan J. Mathis, Yimu Lai, Chen Qu, Joseph S. Janicki and Taixing Cui
DOI: 10.2174/1389450115666141024152421
CYLD-Mediated Signaling and Diseases
The Role of Adipocytokines in Atherogenesis and Atheroprogression
, 16(4): 295 - 320Federico Carbone, Francois Mach and Fabrizio Montecucco
DOI: 10.2174/1389450115666141109213439
The Role of Adipocytokines in Atherogenesis and Atheroprogression
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
, 16(4): 321 - 333Federico Carbone, Francois Mach and Fabrizio Montecucco
DOI: 10.2174/1389450115666141110093013
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
, 16(4): 334 - 341Sabine Steffens and Pal Pacher
DOI: 10.2174/1389450115666141202113225
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
, 16(4): 342 - 360Nathalie Satta and Nicolas Vuilleumier
DOI: 10.2174/1389450115666141125122416
Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Aquaporin-1 and Sodium-Hydrogen Exchangers as Pharmacological Targets in Diabetic Atherosclerosis
, 16(4): 361 - 365Rosalinda Madonna and Raffaele De Caterina
DOI: 10.2174/1389450116666141219115720
Aquaporin-1 and Sodium-Hydrogen Exchangers as Pharmacological Targets in Diabetic Atherosclerosis
Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease
, 16(4): 366 - 372Chiara Barisione, Giorgio Ghigliotti, Marco Canepa, Manrico Balbi, Claudio Brunelli and Pietro Ameri
DOI: 10.2174/1389450116666141230114500
Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease
Macrophages and Dendritic Cells: The Usual Suspects in Atherogenesis
, 16(4): 373 - 382Christina Kassiteridi and Claudia Monaco
DOI: 10.2174/1389450116666150330115809
Macrophages and Dendritic Cells: The Usual Suspects in Atherogenesis
MicroRNAs as Tools and Effectors for Patient Treatment in Gastrointestinal Carcinogenesis
, 16(4): 383 - 392Edoardo D'Angelo, Caterina Vicentini, Marco Agostini, Andras Kiss, Raffaele Baffa, Aldo Scarpa and Matteo Fassan
DOI: 10.2174/1389450116666141210091454
TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
, 16(4): 393 - 408Yun Song and Peter Buchwald
DOI: 10.2174/1389450116666150223115628
TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net